• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    More On ALNEV.PA

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Neovacs S.A. (ALNEV.PA)

    -Paris
    1.02 Up 0.01(0.99%) May 22, 11:35AM EDT
    Add to Portfolio
    Prev Close:1.02
    Open:1.01
    Bid:1.01
    Ask:1.02
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:1.00 - 1.03
    52wk Range:0.93 - 4.04
    Volume:72,108
    Avg Vol (3m):169,255
    Market Cap:24.15M
    P/E (ttm):N/A
    EPS (ttm):-0.36
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in EUR.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Neovacs S.A., a biotechnology company, focuses on active immunotherapy for autoimmune and inflammatory diseases in France. The company’s product pipeline comprises tumor necrosis factor kinoid for the treatment of rheumatoid arthritis and Cro... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback